Skip to main content
. 2016 Aug 8;12(4):2555–2559. doi: 10.3892/ol.2016.4974

Figure 2.

Figure 2.

Kaplan-Meier survival analysis of colorectal cancer (CRC) patients negative or positive for CD168 overexpression. CD168 overexpression was associated with shorter overall survival times. Analysis of (A) all patients, (B) patients with stage I+II CRC and (C) patients with stage III+IV CRC.